Clinical Trial Update: Molecular Biomarkers for Sepsis

View source ↗

Summary

A University Hospital Basel study evaluating molecular biomarkers for sepsis, including severe community-acquired pneumonia, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Community-acquired Pneumonia
• Sepsis

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Sepsis, Severe Community-acquired Pneumonia (sCAP) | Status: TERMINATED